GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Find insight on GSK, Novo Nordisk, tariff escalation and more in the latest Market Talks covering Health Care.

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for an IPO to fund development of vaccines that could compete with companies ...

RSV vaccines respond to a significant unmet medical need,” GSK's spokesperson added on Wednesday. A Pfizer spokesperson reminded in an email that flu vaccines also have been associated with GBS.

and Pfizer (PFE)/GSK (GSK)/CureVac (CVAC) for H5N1 avian flu. The investment firm noted that Moderna (MRNA) and Pfizer (PFE), along with Pfizer (PFE) partner BioNTech (BNTX), were being sued for ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Moderna, Pfizer, and a partnership between GSK and CureVac are reportedly working ... and Prevention reported the first death from bird flu on Monday, announcing an elderly patient with underlying ...

Bird flu has severely impacted poultry farms and ... Other players, including Pfizer and GSK (in collaboration with CureVac), are testing similar candidates. For investors who want to play the ...